[Journal logo]

Volume 68 
Part 9 
Page o2617  
September 2012  

Received 5 July 2012
Accepted 11 July 2012
Online 1 August 2012

Key indicators
Single-crystal X-ray study
T = 125 K
Mean [sigma](C-C) = 0.005 Å
R = 0.043
wR = 0.100
Data-to-parameter ratio = 22.5
Details
Open access

5-Bromo-2-hydroxybenzonitrile

aDepartment of Chemistry, Vassar College, Poughkeepsie, NY 12604, USA
Correspondence e-mail: jotanski@vassar.edu

The title compound, C7H4BrNO, crystallizes with two molecules in the asymmetric unit. The two molecules exhibit nearly linear C-C[triple bond]N nitrile bond angles of 179.1 (4) and 177.1 (4)°. In the crystal, the molecules are linked into a one-dimensional hydrogen-bonded chain by interactions between the phenol H atom and the nitrile N atom [N...O = 2.805 (4) and 2.810 (4) Å].

Related literature

For information on the synthesis of the title compound, see: Anwar & Hansen (2008[Anwar, H. F. & Hansen, T. V. (2008). Tetrahedron Lett. 49, 4443-4445.]); Bonnichon et al. (1999[Bonnichon, F., Grabner, G., Guyot, G. & Richard, C. (1999). J. Chem. Soc. Perkin Trans. 2, pp. 1203-1210.]); Oberhauser (1997[Oberhauser, T. (1997). J. Org. Chem. 62, 4504-4506.]); Tamilselvan et al. (2009[Tamilselvan, P., Basavaraju, Y. B., Sampathkumar, E. & Murugesan, R. (2009). Catal. Commun. 10, 716-719.]). For use as a synthetic reagent, see: Jiang et al. (2011[Jiang, S., Tala, S. R., Lu, H., Abo-Dya, N. E., Avan, I., Gyanda, K., Lu, L., Katritzky, A. R. & Debnath, A. K. (2011). J. Med. Chem. 54, 572-579.]); Tsuhako et al. (2012[Tsuhako, A. L., et al. (2012). Bioorg. Med. Chem. Lett. 22, 3732-3738.]); Wetzel et al. (2011[Wetzel, M., Marchais-Oberwinkler, S., Perspicace, E., Möller, G., Adamski, J. & Hartmann, R. W. (2011). J. Med. Chem. 54, 7547-7557.]). For a related crystal structure, see: Beswick et al. (1996[Beswick, C., Kubicki, M. & Codding, P. W. (1996). Acta Cryst. C52, 3171-3173.]).

[Scheme 1]

Experimental

Crystal data
  • C7H4BrNO

  • Mr = 198.01

  • Triclinic, [P \overline 1]

  • a = 3.8422 (3) Å

  • b = 8.5166 (7) Å

  • c = 21.6507 (18) Å

  • [alpha] = 97.074 (1)°

  • [beta] = 91.991 (1)°

  • [gamma] = 97.068 (1)°

  • V = 696.83 (10) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 5.82 mm-1

  • T = 125 K

  • 0.20 × 0.07 × 0.03 mm

Data collection
  • Bruker APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2007[Bruker (2007). SAINT, SADABS and APEX2. Bruxer AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.389, Tmax = 0.845

  • 11040 measured reflections

  • 4213 independent reflections

  • 3254 reflections with I > 2[sigma](I)

  • Rint = 0.032

Refinement
  • R[F2 > 2[sigma](F2)] = 0.043

  • wR(F2) = 0.100

  • S = 1.03

  • 4213 reflections

  • 187 parameters

  • 2 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 1.67 e Å-3

  • [Delta][rho]min = -0.57 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
O1-H1...N2 0.83 (2) 1.98 (2) 2.805 (4) 170 (5)
O2-H2...N1i 0.84 (2) 1.98 (2) 2.810 (4) 175 (5)
Symmetry code: (i) x-1, y+1, z.

Data collection: APEX2 (Bruker, 2007[Bruker (2007). SAINT, SADABS and APEX2. Bruxer AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2007[Bruker (2007). SAINT, SADABS and APEX2. Bruxer AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXTL.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: RK2372 ).


Acknowledgements

This work was supported by Vassar College. X-ray facilities were provided by the US National Science Foundation (grant No. 0521237 to JMT).

References

Anwar, H. F. & Hansen, T. V. (2008). Tetrahedron Lett. 49, 4443-4445.  [ISI] [CrossRef] [ChemPort]
Beswick, C., Kubicki, M. & Codding, P. W. (1996). Acta Cryst. C52, 3171-3173.  [CrossRef] [details]
Bonnichon, F., Grabner, G., Guyot, G. & Richard, C. (1999). J. Chem. Soc. Perkin Trans. 2, pp. 1203-1210.
Bruker (2007). SAINT, SADABS and APEX2. Bruxer AXS Inc., Madison, Wisconsin, USA.
Jiang, S., Tala, S. R., Lu, H., Abo-Dya, N. E., Avan, I., Gyanda, K., Lu, L., Katritzky, A. R. & Debnath, A. K. (2011). J. Med. Chem. 54, 572-579.  [ISI] [CrossRef] [ChemPort] [PubMed]
Oberhauser, T. (1997). J. Org. Chem. 62, 4504-4506.  [CrossRef] [PubMed] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Tamilselvan, P., Basavaraju, Y. B., Sampathkumar, E. & Murugesan, R. (2009). Catal. Commun. 10, 716-719.  [ISI] [CrossRef] [ChemPort]
Tsuhako, A. L., et al. (2012). Bioorg. Med. Chem. Lett. 22, 3732-3738.  [CrossRef] [ChemPort] [PubMed]
Wetzel, M., Marchais-Oberwinkler, S., Perspicace, E., Möller, G., Adamski, J. & Hartmann, R. W. (2011). J. Med. Chem. 54, 7547-7557.  [ISI] [CrossRef] [ChemPort] [PubMed]


Acta Cryst (2012). E68, o2617  [ doi:10.1107/S1600536812031716 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.